Gonadectomy abrogates sex differences in the effectiveness of chemical carcinogenesis in mice

L Somogyi1, T Jukić, Z Bukovec

  • 1Department of Physiology, School of Medicine, University of Zagreb, Sestre Milosrdnice University Hospital, Croatia.

Neoplasma
|January 1, 1994
PubMed

Insights

Sex hormones significantly influence cancer development. Androgens promote carcinogenesis, while estrogens inhibit it, with gonadectomy altering hormone levels and tumor induction rates.

Area of Science:

  • Endocrinology
  • Oncology
  • Carcinogenesis research

Background:

  • Sex hormones play a role in various physiological processes, including cancer development.
  • Understanding the specific effects of androgens and estrogens on carcinogenesis is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the influence of sex hormones on methylcholanthrene-induced carcinogenesis in mice.
  • To determine the differential effects of androgens and estrogens on tumor induction.
  • To assess the impact of gonadectomy on sex hormone levels and subsequent carcinogenesis.

Main Methods:

  • Male and female mice underwent either sham-gonadectomy or gonadectomy.
  • Mice were administered methylcholanthrene subcutaneously to induce tumors.
  • Hormone concentrations were measured after gonadectomy.
  • Tumor induction rates were compared between groups.

Main Results:

  • Gonadectomy altered endogenous sex hormone concentrations, increasing the opposite sex hormone.
  • Androgens were found to enhance the effectiveness of carcinogenesis.
  • Estrogens demonstrated an inhibitory effect on carcinogenesis.
  • Gonadectomy abolished the observed sex differences in tumor induction.

Conclusions:

  • Sex hormones, specifically androgens and estrogens, significantly modulate the carcinogenic process.
  • Androgenic activity promotes while estrogenic activity inhibits chemical carcinogenesis.
  • Gonadectomy can abrogate sex-based differences in susceptibility to chemical carcinogens.